Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 22 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Creutzfeldt-Jakob disease infection from blood transfusion

A research letter in this week's issue of the Lancet outlines a second case of vCJD infection probably caused by blood transfusion.

News image

fiogf49gjkf04

The first case of variant Creutzfeldt-Jakob disease (vCJD) associated with blood transfusion was announced at the end of last year. At this time researchers identified 17 people who had received blood donated from donors who later went on to develop vCJD.

Now the rogue prion responsible for vCJD has been identified at postmortem 5 years after an elderly person received a blood transfusion from a donor who later developed vCJD.

The case reported today did not have clinical symptoms of vCJD and died of other causes, however this case was 1 of the 17 individuals identified last year.

The current case is the first of its kind to identify a heterozygous genotype for the prion protein, suggesting that a larger population of people could become infected.

Dr James Ironside, from the CJD Surveillance Unit, Edinburgh, Scotland, comments, “This finding has major implications for future estimations of numbers of vCJD cases in the UK, since individuals with this genotype constitute the largest genetic subgroup in the population".

"This subgroup might have a different incubation period after exposure to either primary infection by the bovine spongiform encephalopathy (BSE) agent or secondary infection by blood transfusion".

"A very lengthy incubation period might explain why no clinical cases of vCJD have yet been observed in this subgroup”.

“This case highlights the need for continuing surveillance for CJD in the UK, and strongly reinforces the role of the autopsy in the investigation and diagnosis of both clinical and preclinical forms of human prion disease”.

In an accompanying commentary in the same publication, Dr Kumanan Wilson from Toronto General Hospital and Dr Maura Rickets from Health Canada are supportive of UK policies introduced to limit the spread of vCJD.

With regard to the blood-transfusion case, Dr Wilson comments, “The true clinical and public-health significance, with respect to the issue of whether the individual would have subsequently developed clinically evident vCJD or whether this individual poses a risk for iatrogenic transmission of the disease, remains uncertain".

"Nevertheless, combined with the animal studies by Houston and Hunter and their colleagues showing transfusion transmission of the disease in preclinical models, and the previous case report of probable transfusion transmission, there now appears to be sufficient evidence that individuals without clinical signs of vCJD harbor, and therefore potentially transmit, the infection”.

A policy of leucoreduction for blood transfusion to reduce the risk of possible vCJD transmission was introduced in the UK in 1999.

The authors of a second research letter in this week's Lancet highlight how leucoreduction only reduced infectivity by around 40% in an animal model.

Dr Luisa Gregori from the VA Maryland Health Care System and University of Maryland, USA comments, “Although leucoreduction is a necessary step for removing white-cell-associated TSE infectivity from blood, this process is insufficient to remove the risk from an infected transfusion unit”.

Transmission of vCJD from surgical instruments is another public-health concern, especially as the prion protein responsible for vCJD is resistant to conventional sterilizing procedures.

In an additional article this week, Dr Jean Philippe Deslys and colleagues identify a new technique for disinfecting prion-contaminated medical devices.

They report how specific alkaline agents or an original vaporized hydrogen peroxide treatment can be effective decontaminants without damaging delicate medical or surgical instruments; conventional autoclaving alone does not fully reduce transmission risk and can often damage surgical devices.

Dr Deslys comments, “Decontamination of prions from surgical instruments has been a major problem since vCJD was first identified".

"The results of our study should provide reassurance that practical solutions now exist which can be implemented without delay to reduce risk of prion transmission from medical and surgical instruments”.

Lancet 2004; 364(9433):
06 August 2004

Go to top of page Email this page Email this page to a colleague

 22 February 2018 
Outcomes with Crohn’s after infliximab withdrawal
 22 February 2018 
Elderly onset of IBD

 22 February 2018 
Autophagy enhancers
 21 February 2018 
Management of hemorrhoids in the USA
 21 February 2018 
Adalimumab and infliximab in biologic-naïve Crohn's
 21 February 2018 
Cystic fibrosis and colorectal cancer
 20 February 2018 
Complications and surveillance colonoscopies
 20 February 2018 
Treatment algorithm for polyp cancers
 20 February 2018 
Predictors of postoperative infection in Crohn's
 19 February 2018 
Screening colonoscopy in the right and left colon
 19 February 2018 
NAFLD prevalence in the USA
 19 February 2018 
Fructans in children with IBS

 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis
 26 January 2018 
Optimizing selection of biologics in IBD
 26 January 2018 
Nutritional risk and laparoscopic-assisted gastrectomy outcomes
 25 January 2018 
Patient-reported outcome measure for functional dyspepsia

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us